Comvita Ltd
NZX:CVT
Intrinsic Value
Comvita Ltd. engages in the manufacture and marketing of healthcare, personal care, and functional food products. [ Read More ]
The intrinsic value of one CVT stock under the Base Case scenario is 3.59 NZD. Compared to the current market price of 2.07 NZD, Comvita Ltd is Undervalued by 42%.
Valuation Backtest
Comvita Ltd
Run backtest to discover the historical profit from buying and selling CVT stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Comvita Ltd
Current Assets | 216.7m |
Cash & Short-Term Investments | 12.9m |
Receivables | 49.5m |
Other Current Assets | 154.2m |
Non-Current Assets | 174.8m |
Long-Term Investments | 12.8m |
PP&E | 100.1m |
Intangibles | 51.9m |
Other Non-Current Assets | 10m |
Current Liabilities | 38.9m |
Accounts Payable | 32.7m |
Other Current Liabilities | 6.2m |
Non-Current Liabilities | 116.8m |
Long-Term Debt | 115.2m |
Other Non-Current Liabilities | 1.6m |
Earnings Waterfall
Comvita Ltd
Revenue
|
225.4m
NZD
|
Cost of Revenue
|
-96.9m
NZD
|
Gross Profit
|
128.6m
NZD
|
Operating Expenses
|
-114.1m
NZD
|
Operating Income
|
14.4m
NZD
|
Other Expenses
|
-10.7m
NZD
|
Net Income
|
3.7m
NZD
|
Free Cash Flow Analysis
Comvita Ltd
CVT Profitability Score
Profitability Due Diligence
Comvita Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Comvita Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
CVT Solvency Score
Solvency Due Diligence
Comvita Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Comvita Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CVT Price Targets Summary
Comvita Ltd
According to Wall Street analysts, the average 1-year price target for CVT is 2.17 NZD with a low forecast of 2.12 NZD and a high forecast of 2.26 NZD.
Shareholder Return
CVT Price
Comvita Ltd
Average Annual Return | -3.72% |
Standard Deviation of Annual Returns | 17.16% |
Max Drawdown | -63% |
Market Capitalization | 145.4m NZD |
Shares Outstanding | 70 225 400 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Comvita Ltd. engages in the manufacture and marketing of healthcare, personal care, and functional food products. The company is headquartered in Te Puke, Bay Of Plenty. The company went IPO on 2003-11-14. The firm is engaged in the manufacturing and marketing natural health products, and apiary ownership and management. Its segments include New Zealand, which includes production and extraction facilities at Paengaroa, Northland, Waikato, Whanganui, Wairarapa, Hawkes Bay, East Coast, Nelson and Timaru, and Apiary operations in Northland, Waikato, Whanganui, Wairarapa, Hawkes Bay and East Coast; Australia, which includes over 242 hectares of olive leaf plantation, extraction and manufacturing facility in rural Queensland; Asia, which includes operations in Hong Kong, Taiwan, China, Japan, Korea and South Korea; Europe, which includes the operations in the United Kingdom and European markets; Medical, which includes bulk medical honey sales and royalty payments received from Derma Sciences, Inc., and Other, which captures revenue earned from other areas, including bulk sales, the United States and Canada.
Contact
IPO
Employees
Officers
The intrinsic value of one CVT stock under the Base Case scenario is 3.59 NZD.
Compared to the current market price of 2.07 NZD, Comvita Ltd is Undervalued by 42%.